41-42 NCI Announces First Winners of Its Outstanding Investigator Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NCI Announces First Winners of Its Outstanding Investigator Awards

NCI named the inaugural 43 recipients of its Outstanding Investigator Awards.

Developed last year, the grant program provides funding to investigators with outstanding records of productivity in cancer research to support projects of unusual potential in cancer research.

The award provides funding of up to $600,000 in direct costs each year for seven years. One goal of the award is to provide investigators with substantial time to break new ground or extend previous discoveries to advance biomedical, behavioral or clinical cancer research.

Award recipients are cancer researchers, nominated by their institutions, who have served as a principal investigator on an NCI grant for the last five years.

“The NCI Outstanding Investigator Award addresses a problem that many cancer researchers experience: finding a balance between focusing on their science while ensuring that they will have funds to continue their research in the future,” said Dinah Singer, director of NCI’s Division of Cancer Biology.

“With seven years of uninterrupted funding, NCI is providing investigators the opportunity to fully develop exceptional and ambitious cancer research programs.”

The full list of all 43 individual recipients, details of their research, and links to their work at their respective institutions is available on the NCI website.

NCI is currently accepting applications for the 2016 class of Outstanding Investigators in any area of cancer research. Letters of Intent were due Oct. 23, and final applications are due Nov. 23.

The principle investigator will be expected to commit at least half of their research activities to the award; and the investigator’s institution will be expected to commit at least 20 percent salary support. The NIH grants website lists an earliest start date of July 2016.


President Joe Biden April 9 announced his FY2022 budgetary plans for ARPA-H—Advanced Research Projects Agency-Health—a federal entity designed to “deliver breakthroughs to find cures for cancer and other diseases.” In his initial White House budget proposal—dubbed skinny budget, or budget-lite—Biden is requesting $6.5 billion to fund ARPA-H.  “The discretionary request calls for $6.5 billion to...